Om

Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company focused on developing treatments for severe respiratory diseases, with particular emphasis on fibrotic lung conditions and related disorders. The company’s current portfolio is centered on novel small-molecule therapies designed to address disease pathways that contribute to inflammation, tissue remodeling, and lung function decline. Its work spans drug discovery and clinical development, with programs advancing through early- and mid-stage testing. Vicore Pharma Holding AB operates within the broader pharmaceutical market, where it contributes to innovation in respiratory medicine and targeted therapies for patients with significant unmet medical needs. The company is headquartered in Stockholm, Sweden, and its activities are focused on translating scientific research into therapeutic candidates for specialized disease areas.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I VICORE PHARMA HOLDING - ADR MED ENDAVU: Køb Vicore Pharma Holding - ADR ($VCRE) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Vicore Pharma Holding - ADR, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.